Patent · US Active

eIF4E binding peptides

US9018348B2 · kind B2 · utility

0Cited by
6References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateApr 27, 2011
Grant dateApr 28, 2015
Priority date—
Expiry dateApr 27, 2031

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/10
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to modified eIF4G1 peptides, uses thereof and pharmaceutical compositions comprising the modified eIF4G1 peptides.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.